A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Clinical trial NCT06679829 · RECRUITING
Trial details
- NCT number
- NCT06679829
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-06
- Primary completion
- 2027-11-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.